Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026495737> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2026495737 endingPage "172" @default.
- W2026495737 startingPage "166" @default.
- W2026495737 abstract "Following the commercialisation in France of the varicella vaccine and the European marketing authorization for a vaccine against zoster, this article intends to review the epidemiology of varicella and herpes zoster, to expose the characteristics of the available vaccines, and to consider the advantages and caveats of the different immunisation strategies.In France, from 550.000 to 750.000 cases of varicella are reported each year, which result in more than 3.500 hospitalizations and about 20 deaths. Subjects>or=15 years old represent 8.3% of the total number of cases of varicella, 26% of varicella-related hospitalisations and 69% of all varicella-related deaths. The susceptibility rate for the 15 years old is 10,3 and 79% of these non-immune subjects are expected to contract varicella. The vaccines currently marketed against varicella are safe, have a good immunogenicity and remain effective over the evaluated periods. Two vaccination strategies are considered: a generalized vaccination of the infants and children, or a vaccination targeted against high-risk populations and non-immune teenagers and adults. The incidence of herpes zoster is estimated in France at 235.000 new cases per year, from which 1% is hospitalized. A live attenuated vaccine using the same strain as the varicella vaccine, but at a much higher dose, proved its efficacy in terms of reducing shingles and postherpetic neuralgia incidences, of 51 and 67% respectively. This vaccine received a marketing authorisation in France, for adults>or=60 years old.Uncertainties about the impact of vaccination on varicella and herpes zoster epidemiology have yet to be solved, such as the potential increase in herpes zoster incidence or in the absolute number of diagnosed varicella cases in older age groups, or the loss of vaccination-induced immunity with time. These questions demonstrate the need for an operational real-time surveillance network to monitor varicella and herpes zoster incidence in the setting of general population immunisation." @default.
- W2026495737 created "2016-06-24" @default.
- W2026495737 creator A5005456406 @default.
- W2026495737 creator A5007739277 @default.
- W2026495737 creator A5015993425 @default.
- W2026495737 date "2007-03-01" @default.
- W2026495737 modified "2023-10-01" @default.
- W2026495737 title "Vaccination des adultes contre la varicelle et le zona" @default.
- W2026495737 cites W1418095302 @default.
- W2026495737 cites W1504645184 @default.
- W2026495737 cites W1737209335 @default.
- W2026495737 cites W1973000833 @default.
- W2026495737 cites W1980107617 @default.
- W2026495737 cites W1980492236 @default.
- W2026495737 cites W1985406046 @default.
- W2026495737 cites W1989490043 @default.
- W2026495737 cites W2021515277 @default.
- W2026495737 cites W2024305801 @default.
- W2026495737 cites W2027401316 @default.
- W2026495737 cites W2028934683 @default.
- W2026495737 cites W2030523747 @default.
- W2026495737 cites W2032052547 @default.
- W2026495737 cites W2033062403 @default.
- W2026495737 cites W2033447710 @default.
- W2026495737 cites W2048502930 @default.
- W2026495737 cites W2059510515 @default.
- W2026495737 cites W2071502300 @default.
- W2026495737 cites W2078648045 @default.
- W2026495737 cites W2096848795 @default.
- W2026495737 cites W2104543475 @default.
- W2026495737 cites W2112367671 @default.
- W2026495737 cites W2112481032 @default.
- W2026495737 cites W2118383883 @default.
- W2026495737 cites W2126926729 @default.
- W2026495737 cites W2130793570 @default.
- W2026495737 cites W2131041950 @default.
- W2026495737 cites W2143084676 @default.
- W2026495737 cites W2143235865 @default.
- W2026495737 cites W2143460513 @default.
- W2026495737 cites W2146768400 @default.
- W2026495737 cites W2154139509 @default.
- W2026495737 cites W2154714320 @default.
- W2026495737 cites W2160737599 @default.
- W2026495737 cites W2161014948 @default.
- W2026495737 cites W2331565340 @default.
- W2026495737 cites W2968404159 @default.
- W2026495737 cites W91843362 @default.
- W2026495737 doi "https://doi.org/10.1016/j.revmed.2006.12.004" @default.
- W2026495737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17270316" @default.
- W2026495737 hasPublicationYear "2007" @default.
- W2026495737 type Work @default.
- W2026495737 sameAs 2026495737 @default.
- W2026495737 citedByCount "9" @default.
- W2026495737 countsByYear W20264957372015 @default.
- W2026495737 crossrefType "journal-article" @default.
- W2026495737 hasAuthorship W2026495737A5005456406 @default.
- W2026495737 hasAuthorship W2026495737A5007739277 @default.
- W2026495737 hasAuthorship W2026495737A5015993425 @default.
- W2026495737 hasConcept C29456083 @default.
- W2026495737 hasConcept C71924100 @default.
- W2026495737 hasConceptScore W2026495737C29456083 @default.
- W2026495737 hasConceptScore W2026495737C71924100 @default.
- W2026495737 hasIssue "3" @default.
- W2026495737 hasLocation W20264957371 @default.
- W2026495737 hasLocation W20264957372 @default.
- W2026495737 hasOpenAccess W2026495737 @default.
- W2026495737 hasPrimaryLocation W20264957371 @default.
- W2026495737 hasRelatedWork W1970478260 @default.
- W2026495737 hasRelatedWork W1972897249 @default.
- W2026495737 hasRelatedWork W2044058499 @default.
- W2026495737 hasRelatedWork W2059676233 @default.
- W2026495737 hasRelatedWork W2060796257 @default.
- W2026495737 hasRelatedWork W2070585413 @default.
- W2026495737 hasRelatedWork W2082168333 @default.
- W2026495737 hasRelatedWork W2085282382 @default.
- W2026495737 hasRelatedWork W2213440267 @default.
- W2026495737 hasRelatedWork W2126679181 @default.
- W2026495737 hasVolume "28" @default.
- W2026495737 isParatext "false" @default.
- W2026495737 isRetracted "false" @default.
- W2026495737 magId "2026495737" @default.
- W2026495737 workType "article" @default.